Feliciani, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 2.091
EU - Europa 1.883
AS - Asia 1.531
SA - Sud America 304
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 5.844
Nazione #
US - Stati Uniti d'America 2.054
SG - Singapore 808
DE - Germania 744
CN - Cina 411
SE - Svezia 280
BR - Brasile 250
UA - Ucraina 250
IT - Italia 131
FR - Francia 119
GB - Regno Unito 85
IE - Irlanda 84
IN - India 81
FI - Finlandia 73
ID - Indonesia 56
VN - Vietnam 52
RU - Federazione Russa 46
JP - Giappone 23
AR - Argentina 22
TR - Turchia 22
BD - Bangladesh 19
CA - Canada 19
PL - Polonia 18
BE - Belgio 16
NL - Olanda 13
EC - Ecuador 12
IQ - Iraq 12
MX - Messico 9
IR - Iran 7
MA - Marocco 7
SA - Arabia Saudita 7
HK - Hong Kong 6
VE - Venezuela 6
ZA - Sudafrica 6
CL - Cile 5
KE - Kenya 5
LT - Lituania 5
TN - Tunisia 5
UZ - Uzbekistan 5
EU - Europa 4
PK - Pakistan 4
AU - Australia 3
BY - Bielorussia 3
CO - Colombia 3
CR - Costa Rica 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LU - Lussemburgo 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
ES - Italia 1
ET - Etiopia 1
GR - Grecia 1
GY - Guiana 1
JM - Giamaica 1
JO - Giordania 1
MD - Moldavia 1
ML - Mali 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
TH - Thailandia 1
TW - Taiwan 1
Totale 5.844
Città #
Singapore 389
Chandler 372
Ashburn 165
Jacksonville 120
San Mateo 115
Nanjing 83
Dublin 78
Wilmington 75
Dallas 74
Beijing 66
Woodbridge 60
New York 59
Jakarta 50
Nürnberg 44
Houston 42
Ann Arbor 41
Hefei 40
Los Angeles 38
Lawrence 37
Munich 37
Redmond 34
Dearborn 32
Milan 30
Moscow 30
Redwood City 26
Nanchang 25
Ho Chi Minh City 24
Mountain View 23
Seattle 22
Cattolica 21
São Paulo 21
Boston 20
Frankfurt am Main 20
Tianjin 18
Marseille 17
Scottsdale 16
Bremen 14
Buffalo 14
Princeton 14
Izmir 13
Shenyang 13
Boardman 12
Brussels 12
Fairfield 12
Hebei 12
Helsinki 12
Kunming 12
Hangzhou 11
Leawood 11
Santa Clara 11
Turku 11
London 9
Rome 9
Zhengzhou 9
Norwalk 8
San Francisco 8
Shanghai 8
Warsaw 8
Brooklyn 7
Cambridge 7
Hanoi 7
Jiaxing 7
Tokyo 7
University Park 7
Amsterdam 6
Brasília 6
Changsha 6
Chicago 6
Curitiba 6
Fremont 6
Guayaquil 6
Hong Kong 6
Kent 6
Lancaster 6
Phoenix 6
Ribeirão Preto 6
Ypsilanti 6
Atlanta 5
Belo Horizonte 5
Chennai 5
Haiphong 5
Lanzhou 5
Millbury 5
Newark 5
Rio de Janeiro 5
Tashkent 5
Toronto 5
Ankara 4
Baghdad 4
Buenos Aires 4
Denver 4
Guangzhou 4
Johannesburg 4
Kish 4
Kraków 4
Nairobi 4
Orem 4
Ottawa 4
Roubaix 4
Sacramento 4
Totale 2.829
Nome #
Ocular mucous membrane pemphigoid after Lyell syndrome: occasional finding or predisposing event? 212
Atypical multifocal cutaneous leishmaniasis in an immunocompetent patient treated by liposomal amphotericin B 204
Angiokeratoma: decision-making aid for the diagnosis of Fabry disease 180
Updated review of the pathogenesis and management of Merkel cell carcinoma 172
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 169
Linear atrophoderma of Moulin 168
Serum interleukin-18 in children with Henoch-Schonlein purpura: a promising marker of disease activity? 166
The impact of fever/hyperthermia in the diagnosis of Fabry: A retrospective analysis. 155
Updated review of the pathogenesis and management of Merkel cell carcinoma 153
Exacerbation of pemphigus after influenza vaccination. 152
The impact of fever/hyperthermia in the diagnosis of Fabry: A retrospective analysis 147
Systemic complications of esophageal lichen planus 145
A glass of red wine to keep vascular disease at bay, but what about pemphigus vulgaris? 144
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 140
Circumscribed pityriasis rubra pilaris type IV 136
Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases 135
Occupational contact dermatitis from carbapenems 134
Small lymphocytic lymphoma in a patient with Fabry disease 127
Dysplastic nevi, cutaneous melanoma, and other skin neoplasms in patients with myotonic dystrophy type 1: a cross-sectional study 122
TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept 120
IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses 119
Adult self-healing papular mucinosis on genital skin 117
TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept 116
Dermatological signs during inflammatory bowel diseases 114
Small lymphocytic lymphoma in a patient with Fabry disease 114
Dyshidrosiform pemphigoid: a well-defined clinical entity? 113
Alteration of cholinergic system in keratinocytes cells produces acantholysis: a possible use of cholinergic drugs in pemphigus vulgaris 113
Vascular Endothelial Growth Factor (VEGF-a) in Fabry disease: Association with cutaneous and systemic manifestations with vascular involvement 112
Acquired Epidermodysplasia Verruciformis: A Comprehensive Review and a Proposal for Treatment 111
Modelling the resource implications of managing adults with Fabry disease in Italy 109
Cerebral Hemorrhage in a Paucisymptomatic Young Patient with Fabry Disease 109
Adjuvant therapy for resected stage III melanoma patients: high-dose interferon-alpha versus ipilimumab combined with kinases inhibitors 108
Paraneoplastic acrokeratosis (Bazex Syndrome) in lung cancer 103
Fabry disease: a review of current management strategies 103
Fabry disease: a review of current management strategies 100
Psoriatic Pseudobalanitis Circinata as a Post-Viral Koebner Phenomenon 99
Herpes simplex virus infection in pemphigus vulgaris: clinical and immunological considerations 97
Dyshidrosiform pemphigoid: a well-defined clinical entity? 97
Mutation identification of Fabry disease in families with other lysosomal storage disorders 91
Proinflammatory cytokine production in HaCaT cells treated by eosin: implications for the topical treatment of psoriasis 90
Proinflammatory cytokine production in HaCaT cells treated by eosin: implications for the topical treatment of psoriasis 90
Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS) 78
Early-onset basal cell carcinoma in a case of Ivemark syndrome 78
Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases 74
IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses 70
Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS) 68
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data 65
Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey 65
Home treatment with intravenous enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II - data from the Hunter Outcome Survey 59
Totale 5.863
Categoria #
all - tutte 22.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021273 0 0 0 0 0 33 68 21 59 19 68 5
2021/2022431 50 50 12 16 26 17 5 86 11 20 57 81
2022/2023918 134 137 85 137 90 104 31 68 108 4 17 3
2023/2024349 25 115 5 25 6 49 15 6 2 15 44 42
2024/2025824 23 22 58 61 50 16 4 39 162 75 152 162
2025/20261.274 369 57 156 180 447 65 0 0 0 0 0 0
Totale 5.863